3.An experimental study of acutobin and heparin on acute inferior vena cava thrombus in rabbits
Yilai SUN ; Yu ZHAO ; Zhi XIANG ; Zhonghui ZOU
Chinese Journal of General Surgery 2010;25(7):562-565
Objective To investigate the effectiveness and safety of combined heparin and acutobin in the treatment of acute inferior vena cava thrombus in rabbits. Methods The inferior vena cava thrombus model was established in 72 rabbits and they were randomly divided into three groups; heparin group(A) , group for combination of urokinase and heparin (B), group for combination of acutobin and heparin (C) ,each group including 24 rabbits. Drugs were administrated 3 days after thrombosis. Coagulation indexes were tested to assess their safety, and Doppler ultrasound was used to assess their effectiveness, on day 3, day 7, and day 10. Results The prolongation of prothrombin time ( PT) in group C was shorter than that in group B( P < 0. 05 ) , the fibrinogen ( FBG) value in group C was lower than that in group B (P < 0. 05 ) , the prolongation of PT in group B and group C was longer than that in group A (P < 0. 01), the FBG value of group B and C were higher than that in group A ( P < 0. 01 ), D-dimer ( D-D) value in group B and C gradually returned to normal range. There was no difference between the two groups (P > 0. 05). The thrombolytic effect in group B and C were better than that in group A, statistical difference was reached between groups B and A (P <0. 01), and the difference was statistically significant between groups C and A 10 days after administration (P < 0. 01). Thrombolytic effect was not different statistically between groups B and C (P > 0. 05). Conclusion Acutobin combined with heparin in the treatment of acute inferior vena cava thrombus in rabbits was effective and safe.
4.Recovery prediction of danshensu,salvianolic acid B,and salvianolic acid D in danshen ethanol precipitation
Xiang YU ; Biqi MO ; Zhi WANG ; Haibin QU
Chinese Traditional and Herbal Drugs 1994;0(06):-
Objective To develop recovery prediction models for danshensu,salvianolic acid B,and salvianolic acid D in danshen ethanol precipitation.Methods Recorded the operation parameters of 15 normal batches of danshen ethanol precipitation in one Chinese medicine plant and measured five active component contents in danshen concentrated liquid and danshen ethanol precipitated liquid,the Stepwise-MLR recovery prediction models of dashensu,salvianolic acid B,and salvianolic acid D were developed based on an approach which combined the process parameters and the active component contents in danshen concentrated liquid.The importance of variables in the prediction models was analyzed later.Results The coefficient correlations of dashensu,salvianolic acid B,and salvianolic acid D recovery prediction models were all above 0.95.Conclusion The models developed for active component recovery prediction show a good predictability.Models can be used to help manufacturers to understand the ethanol precipitation process and improve the quality control ability of danshen ethanol precipitation.
5.Research progress of non-coding RNA in posterior capsule opacification
Bing-Yu, ZHANG ; Zhi-Xiang, DING ; Yang, CHEN
International Eye Science 2017;17(6):1069-1072
Posterior capsule opacification (PCO) is the most common complication after cataract surgery.How to prevent and treat PCO is an urgent problem we need to solve at present.Non-coding RNA(ncRNA) is a kind of RNA, which can not encode proteins.Studies have shown that non-coding RNA is closely related to the occurrence and development of human diseases.This paper has collected the progress of research on different kinds of ncRNA in PCO and may raise new ideas and methods on the prevention and treatment of PCO.
6.Effects of Fosinopril on Transforming Growth Factor-Beta 1 Secretion and mRNA Expression of Cultured Rats Glomerular Mesangial Cell
li-na, WANG ; zhi-hong, HAO ; zhi-yuan, WENG ; li, YU ; you-xiang, ZHANG
Journal of Applied Clinical Pediatrics 2006;0(13):-
Objective To observe the effects of fosinopril(FOS),a new generation angiotensin-converting enzyme inhibitor(ACEI),on protein and mRNA expression of transforming growth factor-?_1(TGF-?_1) of rat glomerular mesangial cell(GMC) induced by lipopolysaccharide(LPS);to demonstrate the preventive mechanism against glomerular sclerosis by applying FOS.Methods The cultured GMC in classic way were divided into 3 groups:control group;LPS group;LPS+FOS group.TGF-?_1 concentration in GMC supernatant fluid was detected by ELISA;TGF-?_1 mRNA expression was determined by semiquantitative real-time RT-PCR.Results LPS group was obviously higher than control groups in TGF-?_1 secretion and mRNA expression,while LPS+FOS group decreased distinctively in TGF-?_1 secretion and mRNA expression compared with LPS group.Conclusions FOS has obviously inhibited on TGF-?_1 expression of rat GMC both at protein level and mRNA level,which reveals that it may be an important mechanism by FOS on restraining the development of glomerulosclerosis.
7.Identification of a novel mutation of C1 inhibitor gene in a Chinese family with hereditary angioedema.
Yu-xiang ZHI ; Hong-yu ZHANG ; Shang-zhi HUANG
Acta Academiae Medicinae Sinicae 2003;25(6):664-666
OBJECTIVETo identify the mutation of C1 inhibitor (C1 INH) gene in a Chinese family with hereditary angioedema (HAE).
METHODSPolymerase chain reaction and direct sequencing were used to identify the mutation type. The sequencing results were compared with the normal sequences in GenBank to find the mutation. In order to exclude the polymorphism, 30 normal volunteers were analyzed.
RESULTSOne novel mutation (17839 del C) was detected in 5 patients with HAE. The mutation was not found in controls.
CONCLUSIONThe mutation of C1 INH gene (17839 del C) is identified in the family. Molecular diagnosis can be made by detecting the mutation.
Angioedema ; genetics ; Chromosomes, Human, Pair 11 ; genetics ; Complement C1 ; genetics ; Complement C1 Inactivator Proteins ; genetics ; Exons ; Family Health ; Female ; Humans ; Male ; Pedigree ; Point Mutation ; Sequence Deletion
9.Design, synthesis and antiproliferative activities of artemisinin derivatives substituted by N-heterocycles.
Zhi-zhong ZUO ; Hang ZHONG ; Ting CAI ; Yu BAO ; Zhi-qiang LIU ; Dan LIU ; Lin-xiang ZHAO
Acta Pharmaceutica Sinica 2015;50(7):868-874
Increasing attention has been focused on the antitumor activity of artemisinin derivatives in recent years, for artemisinin had been reported to have cytotoxic effects against HL-60, P388 and MCF-7 tumor cells. We report here the synthesis and evaluation for antitumor activity of a series of artemisinin-ether derivatives bearing tetrahydropyrrole, morpholine, piperidine, substituted piperidines and azoles with various linkers. Sixteen 10-O-substituted dihydroartemisinin derivatives were designed and synthesized, all of which have never been reported in literatures and whose antiproliferative effects on human breast cancer MCF-7, MCF-7/Adr and HL-60 cells were determined by MTT assay or direct cell counting. Each of these artemisinin derivatives possessed better effects than dihydroartemisinin evidently against HL-60 and MCF-7 cells growth, while less potent than doxorubicin. All target compounds exhibited significantly improved potency compared to DHA and doxorubicin on the doxorubicin-resistant MCF-7/Adr cells, so did they in their sensitive counterparts MCF-7 cells. Among them, compounds GF02, GH04 and ZH04 showed strong activity against these three cell lines growth. Further research is undergoing.
Antineoplastic Agents
;
chemical synthesis
;
chemistry
;
Artemisinins
;
chemical synthesis
;
chemistry
;
Breast Neoplasms
;
pathology
;
Cell Proliferation
;
Doxorubicin
;
Drug Design
;
HL-60 Cells
;
drug effects
;
Humans
;
MCF-7 Cells
;
drug effects
10.Cervical carcinoid with high-grade intraepithelial neoplasia: report of a case.
Hai LI ; Fang BAO ; Yu-fei LI ; Yi-long DAI ; Ying XIANG ; Zhi-hong ZHANG
Chinese Journal of Pathology 2013;42(5):347-348
Adult
;
Breast Neoplasms
;
metabolism
;
pathology
;
secondary
;
Carcinoid Tumor
;
metabolism
;
pathology
;
surgery
;
Carcinoma, Adenoid Cystic
;
pathology
;
Carcinoma, Lobular
;
metabolism
;
pathology
;
secondary
;
Cervical Intraepithelial Neoplasia
;
metabolism
;
pathology
;
surgery
;
Chromogranin A
;
metabolism
;
Diagnosis, Differential
;
Female
;
Humans
;
Hysterectomy
;
Keratins
;
metabolism
;
Neoplasms, Multiple Primary
;
metabolism
;
pathology
;
surgery
;
Ovarian Neoplasms
;
metabolism
;
pathology
;
Sex Cord-Gonadal Stromal Tumors
;
metabolism
;
pathology
;
Synaptophysin
;
metabolism
;
Uterine Cervical Neoplasms
;
metabolism
;
pathology
;
surgery